Invivyd Elects Two New Independent Members to its Board of Directors

WALTHAM, Mass., May 22, 2024 -- Invivyd, Inc. , a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that two new independent...

Related Keywords

Waltham ,Leicestershire ,United Kingdom ,Cambridge ,Cambridgeshire ,Clive Meanwell ,Michaels Wyzga ,Marc Elia ,Tom Heyman ,Srishti Gupta ,Kevinf Mclaughlin ,Board Of Directors Vericel Corporation ,Mckinsey Company ,Chairperson Of The Compensation Committee ,Regeneron Pharmaceuticals ,Nasdaq ,Board Of Directors At Idorsia Pharmaceuticals ,Northeastern University ,Pharmaceuticals Incorporated ,Harvard Kennedy School Of Government ,Harvard College ,Harvard Medical School ,Chairperson Of The Audit Committee ,Acceleron Pharma Inc ,Merck Co Inc ,Invivyd Inc ,Exchange Commission ,Mckinsey Global Health Practice ,University Of Cambridge ,Harvard Graduate School Of Arts ,Compensation Committee ,Invivyd Board ,Mckinsey Global Health ,Idorsia Pharmaceuticals ,Harvard Kennedy School ,Natural Science ,Cellular Biology ,Harvard Graduate School ,Senior Vice President ,Chief Financial Officer ,Acceleron Pharma ,Chief Executive Officer ,Vericel Corporation ,Combined Therapeutics ,Decibel Therapeutics ,Graduate School ,Private Securities Litigation Reform Act ,Annual Report ,